Cedar Wealth Management’s DexCom DXCM Stock Holding History

Cedar Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21	Closed	-$2.91K	–	316
2024 Q1	$2.91K	Buy	+21	New	+$2.64K	﹤0.01%	304

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cedar Wealth Management's DXCM Position: Q2 2024 in Review

Cedar Wealth Management sold out of DexCom (DXCM) in Q2 2024, closing a stake of 21 shares — an estimated $2.91K sold.

Cedar Wealth Management first reported a position in DXCM in Q1 2024 and held it in 1 quarter. The position peaked at $2.91K in Q1 2024. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

Cedar Wealth Management reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
Cedar Wealth Management sold 21 DexCom shares in Q2 2024, an estimated $2.91K.
Cedar Wealth Management first reported a position in DexCom in Q1 2024 and held it in 1 quarter.
Cedar Wealth Management's DexCom position peaked at $2.91K in Q1 2024.
999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Cedar Wealth Management's 13F filing for Q2 2024, filed 12 Aug 2024.